Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes

Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes

US Patent 5521085 · Granted May 28, 1996

Estimated economic value: $108,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antiviral drugs containing heteropolyanions2003
4′-C-ethynyl pyrimidine nucleosides and pharmaceutical compositions thereo2002
4'-C-ethynyl pyrimidine nucleoside compounds and pharmaceutical compositions2001
Arylthiadiazole derivative and antiviral agent containing the same1999
Freeze-dried preparation containing monoclonal antibody1999
Anti-VEGF human monoclonal antibody1998
Antiviral agent containing benzodithiin derivative as active ingredient1997
Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for prot1992
Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for prot1992
Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for pret1987
Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for pret1987
Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent1986